For the second year in a row, the ARK.CRYO team is pleased to share a comprehensive Year in Review with our partners, clinics, and patients worldwide. This report captures another year of growth, expanding geographic reach, and operational precision across global cryogenic logistics for reproductive medicine and advanced cell−based therapies.
As you scroll through the report, you will find visual summaries highlighting the scale of our operations, the diversity of biomaterials transported, and the global footprint of our medical courier network. Together, these insights reflect how ARK.CRYO continues to support fertility care, research, and innovation across borders.
Key Achievements
2025 marked a strong year of progress for ARK.CRYO. Over the course of the year, our team completed 1,000+ international and domestic shipments, reaching 59 unique countries, 222 cities, and partnering with 355 fertility clinics worldwide.
These milestones reflect not only operational growth, but also the increasing global demand for reliable, time−critical transport solutions in assisted reproduction and related medical fields.
Biomaterials Transported
Throughout 2025, ARK.CRYO handled a wide range of highly sensitive biomaterials in support of fertility treatment, preservation programs, and regenerative medicine initiatives. Each shipment required strict temperature control, regulatory compliance, and close coordination between clinics, laboratories, and couriers.
The visual breakdown below illustrates the distribution of biomaterials transported during the year.
Distances Traveled by Medical Couriers
In 2025, ARK.CRYO medical couriers collectively traveled 2,845,500 kilometers, supporting secure and timely shipments across continents.
This distance is equivalent to traveling around the Earth’s diameter 71 times, or making a journey to the Moon approximately 7.4 times. These figures underscore the scale of our global operations and the dedication of our courier team, whose expertise remains central to every successful mission.
Top Medical Couriers of 2025
The reliability of ARK.CRYO’s services is built on the professionalism and commitment of our medical couriers. In 2025, several team members stood out for their exceptional contribution, completing a high volume of complex international missions.
Among this year’s top−performing couriers are Olga Zadorozhniak, Ivan Pidtserkovnyi, and Jakub Chmelovsky. Their experience, consistency, and attention to detail played a critical role in supporting time−sensitive shipments across multiple regions.
The chart below highlights the top 10 medical couriers in 2025.
Worldwide Coverage
ARK.CRYO’s operations in 2025 spanned all inhabited continents, reaching both established fertility hubs and emerging destinations. Our teams navigated diverse regulatory environments and logistical conditions to ensure continuity of care across borders.
The visuals below illustrate the number of countries served per continent, emphasizing the truly global reach of ARK.CRYO’s logistics network.
Top Countries by Deliveries
In 2025, shipments were concentrated in regions with high demand for fertility treatment and cross−border reproductive care. The ranking below reflects countries with the highest shipment volumes, highlighting ARK.CRYO’s role in supporting international treatment pathways.
Countries by Cities Served
Geographic depth within each country remains a key indicator of operational maturity. The visual below highlights countries with the broadest city−level coverage, demonstrating ARK.CRYO’s ability to operate beyond major metropolitan centers.
Countries by Clinics Served
Strong collaboration with fertility clinics is central to ARK.CRYO’s work. Throughout 2025, our couriers supported coordinated treatment timelines and laboratory standards across hundreds of clinical partners worldwide.
to unlock even more benefits of partnering with ARK.CRYO.
The chart below showcases countries with the highest number of clinics served during the year.
Supply Ratio by Distance
In 2025, ARK.CRYO shipments were categorized by distance based on the approximate geographic range between pick−up and drop−off locations:
- Short−distance routes (<1,000 km): Regional and nearby cross−border shipments, typically within the same country or between neighboring countries. 15% of total shipments in 2025.
- Medium−distance routes (1,000–5,000 km): International and extended regional shipments requiring advanced coordination and regulatory alignment. 38% of total shipments.
- Long−distance routes (>5,000 km): Intercontinental shipments involving complex logistics, long transit times, and strict temperature control. 43% of total shipments.
This distribution reflects the growing internationalization of fertility care and the increasing demand for specialized long−distance transport solutions.
United States Market Overview
The United States remained a strategic focus for ARK.CRYO in 2025. Our presence was strengthened through continued collaboration with organizations such as Men Having Babies and SEEDS, as well as active participation in key industry events, including ASRM.
Together, these initiatives supported deeper engagement with clinics, intended parents, and industry partners, reinforcing ARK.CRYO’s position as a trusted provider of cryogenic transport services within the U.S. fertility ecosystem.
In total, ARK.CRYO completed 107 domestic shipments within the United States during the year.
Top U.S. Cities Served
Within the United States, ARK.CRYO’s operations extended to a wide network of clinics and laboratories. In 2025, the highest concentration of shipments was recorded in Los Angeles, San Diego, and New York City, reflecting strong clinical demand and well−established fertility infrastructure in these metropolitan areas.
Conclusion
2025 was a year of measurable growth, expanded geographic reach, and continued trust from clinics and partners worldwide. Each shipment represented a carefully coordinated effort to support patients, clinicians, and researchers at critical moments in their work.
We are grateful to our partners, couriers, and collaborators for their confidence in ARK.CRYO. As reproductive medicine and cell−based therapies continue to evolve globally, we remain committed to delivering precision, care, and reliability across every route we serve.
Thank you for being part of our journey.
ARK.CRYO Team
